Zhejiang Jolly Pharmaceutical Co (SZSE:300181) Future 3-5Y EPS without NRI Growth Rate : 26.89 (As of May. 30, 2025)

View and export this data going back to 2011. Start your Free Trial

What is Zhejiang Jolly Pharmaceutical Co Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Zhejiang Jolly Pharmaceutical Co's Future 3-5Y EPS without NRI Growth Rate is 26.89.

Competitive Comparison of Zhejiang Jolly Pharmaceutical Co's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - General subindustry, Zhejiang Jolly Pharmaceutical Co's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zhejiang Jolly Pharmaceutical Co's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Jolly Pharmaceutical Co's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Zhejiang Jolly Pharmaceutical Co's Future 3-5Y EPS without NRI Growth Rate falls into.

Save Embed

;

Save Embed

;

Zhejiang Jolly Pharmaceutical Co (SZSE:300181) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Zhejiang Jolly Pharmaceutical Co Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Zhejiang Jolly Pharmaceutical Co's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Jolly Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Jolly Pharmaceutical Co Ltd (SZSE:300181) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No 388 Zhiyuan North Road, Moganshan Economic, Development Zone, Deqing, CHN, 313200

Website

http://www.zuoli.com

Zhejiang Jolly Pharmaceutical Co Ltd is a China-based company engaged in the production and distribution of pharmaceutical products. Its production lines include raw materials, tablets, capsules, particles and frozen dry powder injection. Its products include Wuling powder, Wuling capsule, linglianhua particle, clindamycin phosphate injection and other.

Executives

Shen Ai Ying	Executives
Chen Guo Fen	Executives
Yu You Qiang	Director
Chen Jian	Executives
Zheng Xue Gen	Director
Guo Yin Li	Supervisors
Wang Tao	Executives
Yang Jun De	Director
Chen Rui Xiang	Supervisors
Dong Hong Yu	Directors, executives
Zheng Chao Yi	Directors, executives
Zhu Xiao Ping	Executives
Wu Ying	Securities Affairs Representative

Zhejiang Jolly Pharmaceutical Co Headlines

No Headlines